NantHealth Statistics
Share Statistics
NantHealth has 0
shares outstanding. The number of shares has increased by 0%
in one year.
| Shares Outstanding | n/a |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 53 |
| FTD / Avg. Volume | 0.03% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -0.41 and the forward
PE ratio is null.
NantHealth's PEG ratio is
-0.03.
| PE Ratio | -0.41 |
| Forward PE | n/a |
| PS Ratio | 0.42 |
| Forward PS | n/a |
| PB Ratio | -0.12 |
| P/FCF Ratio | -0.73 |
| PEG Ratio | -0.03 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for NantHealth.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.35,
with a Debt / Equity ratio of -1.19.
| Current Ratio | 0.35 |
| Quick Ratio | 0.35 |
| Debt / Equity | -1.19 |
| Debt / EBITDA | -7.04 |
| Debt / FCF | -6.9 |
| Interest Coverage | -3.64 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $183,567.12 |
| Profits Per Employee | $-185,695.89 |
| Employee Count | 365 |
| Asset Turnover | 0.42 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -317K |
| Effective Tax Rate | 0.47% |
Stock Price Statistics
The stock price has increased by 0% in the
last 52 weeks. The beta is 1.82, so NantHealth's
price volatility has been higher than the market average.
| Beta | 1.82 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 2.03 |
| 200-Day Moving Average | 3.92 |
| Relative Strength Index (RSI) | 34.94 |
| Average Volume (20 Days) | 197,968 |
Income Statement
In the last 12 months, NantHealth had revenue of 67M
and earned -67.78M
in profits. Earnings per share was -8.8.
| Revenue | 67M |
| Gross Profit | 38.16M |
| Operating Income | -51.33M |
| Net Income | -67.78M |
| EBITDA | -37.98M |
| EBIT | -53.98M |
| Earnings Per Share (EPS) | -8.8 |
Full Income StatementBalance Sheet
The company has 1.76M in cash and 267.4M in
debt, giving a net cash position of -265.64M.
| Cash & Cash Equivalents | 1.76M |
| Total Debt | 267.4M |
| Net Cash | -265.64M |
| Retained Earnings | -1.12B |
| Total Assets | 146.48M |
| Working Capital | -175.76M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -32.26M
and capital expenditures -6.47M, giving a free cash flow of -38.73M.
| Operating Cash Flow | -32.26M |
| Capital Expenditures | -6.47M |
| Free Cash Flow | -38.73M |
| FCF Per Share | -5.03 |
Full Cash Flow StatementMargins
Gross margin is 56.96%, with operating and profit margins of -76.61% and -101.16%.
| Gross Margin | 56.96% |
| Operating Margin | -76.61% |
| Pretax Margin | -101.63% |
| Profit Margin | -101.16% |
| EBITDA Margin | -56.69% |
| EBIT Margin | -76.61% |
| FCF Margin | -57.81% |
